| 摘要 |
FIELD: medicine.SUBSTANCE: invention relates to medicine, in particular to ophthalmology, and can be used for treatment of optic nerve atrophy of different etiology. Tree-component complex is implanted to patient in such a way that it covers optic nerve, posterior short ciliary arteries and part of retrobulbar cellular tissue, without joining them. Three-component complex contains mesenchymal stem cells, labeled with magnetic microparticles. Cells are transposed into biological or synthetic fine-porous material, which is tightly connected with polymer magnetic material with induction of constant magnetic field 1.5 mT, with multi-polar reversible magnetisation.EFFECT: invention ensures improvement or stable stabilisation of visual functions, extension of vision field boundaries, acceleration of hemodynamics in retina and optic nerve.2 cl |
